LARisa Yedigarova, MD PhD - Recent Publications

Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease

Tan, Yedigarova, Inzucchi et al. Cardiovascular Diabetology (2023) 22:319 https://pubmed.ncbi.nlm.nih.gov/37985992/

Cardiovascular Events in Adults with Type 2 Diabetes and ASCVD Initiating Once-Weekly Semaglutide vs DPP-4is in the USA

Inzucchi, Yedigarova et al. Diabetes Ther. 2024 Dec 17;16(2):187–203

https://pmc.ncbi.nlm.nih.gov/articles/PMC11794941/

Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update

Brin, Yedigarova et al. Neurology. 2023 Jul 11;101(2): e103-e113

https://pubmed.ncbi.nlm.nih.gov/37137724/

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review

Blumenfeld, Yedigarova et al. Pain Ther. 2021 Dec;10(2):809-826

https://pubmed.ncbi.nlm.nih.gov/33880725/

Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria

Colantonio, Yedigarova, et al. Cardiovasc Drugs Ther. 2019 Apr;33(2):189-199

https://pubmed.ncbi.nlm.nih.gov/30746585/

Projects and Awards

Eversense MObile Clinic

In my role leading market development at Senseonics, I had the opportunity to develop and oversee the Eversense Mobile Clinic, an innovative, scalable initiative designed to expand awareness, deliver clinical training, and drive adoption of the Eversense implantable CGM system. During its U.S. tour, the mobile clinic achieved millions of impressions, trained thousands of healthcare professionals, and engaged hundreds of patient visitors, resulting in hundreds of lead conversions—successfully accelerating market penetration and clinical adoption.

Gold Award, Best Total Integration Program for Large Companies: Connect The Dots

Presented by Medical Marketing and Media (MM&M) to

Medtronic Diabetes for Connect the Dots

Connect the Dots is a comprehensive four phase educational program to help increase use of Medtronic Diabetes iPro Continuous Glucose Monitor (CGM). Results were outstanding: in just 9 months iPro use among program participants increased nearly 6X.

Disclaimer

The materials, images, videos, and other content displayed on this website (collectively, the “Content”) are intended solely for portfolio and informational purposes. The Content may include works produced collaboratively, works to which I contributed in part, or works created under the direction of others. Accordingly, I do not claim sole authorship or ownership of all Content presented. All rights in third-party materials are retained by their respective owners. No part of this website shall be construed as a claim of exclusive authorship or copyright ownership unless explicitly stated.

LARisa Yedigarova, MD PhD - Recent Publications

Projects and Awards

Eversense MObile Clinic

Gold Award, Best Total Integration Program for Large Companies: Connect The Dots

This website uses cookies.